Collectively, these findings confirm that P3H4 silencing effectively suppresses HCC tumor growth in vivo, highlighting the critical role of P3H4 in maintaining PI3K/AKT pathway activation and sustaining glycolytic metabolism during HCC progression. Here, AKT1 is linked to hepatocellular carcinoma.